All In MedTech

FDA Clearance Tracker · P860026-S009

Avery Diaphragm Pacing System (alson known as Breathing Pacemaker System)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 21, 2026Latest source record: Nov 4, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P860026-S009
Device name
Avery Diaphragm Pacing System (alson known as Breathing Pacemaker System)
Applicant location
Commack, NY
Received
Sep 27, 2017
Decided
Nov 4, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P860026

Device type

Device class
Class III
Regulation
21 CFR 882.5830

Every decision under product code GZE

FDA's approval statement

As written in FDA's record.

Approval to replace the Mark IV transmitter with the digital Spirit transmitter.

Source documents

Other decisions for Avery Biomedical Devices, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.